Accessibility Statement

Leadership Team

RedCarbonPharm is led by a team with deep experience across pharmaceutical strategy, commercialisation, intellectual property, and regulated product development, bringing together the expertise required to navigate complex regulatory, technical, and commercial environments.

Susan Glenny

Over 25 years’ experience in pharmaceutical leadership roles
Senior strategic marketing and commercial roles at global pharmaceutical companies
Founder and director of multiple healthcare-related ventures, with a focus on sustainable innovation and societal impact

John Young

Extensive experience in pharmaceutical operations and commercial execution
Background in supporting product development, scale-up, and cross-functional delivery in regulated environments
Focused on translating strategic intent into operationally viable programmes

Andrew Dean

Nearly 25 years’ experience across sales, marketing, partnering, and strategy in life sciences
Significant expertise in acquisitions, divestments, and strategic partnerships
Deep understanding of commercial value creation across pharmaceutical portfolios

Rikard Kange

Almost 20 years’ experience as a patent attorney in life sciences, pharmaceuticals, and materials science
Specialist expertise in intellectual property strategy for regulated healthcare technologies
Trusted advisor on complex patent matters spanning chemistry, materials, and process innovation

Susanne West PhD

Extensive experience in pharmaceutical operations and commercial execution
Background in supporting product development, scale-up, and cross-functional delivery in regulated environments
Focused on translating strategic intent into operationally viable programmes

Cressida Robson

25 years proven experience in global healthcare companies (Gilead, Eisai) and agencies.
Strong background in strategic communications and policy across diverse international markets and stakeholders